Legal Representation
Attorney
Richard L. Byrne, Registration No. 28,498
USPTO Deadlines
Next Deadline
455 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-10-20)
Due Date
October 20, 2026
Grace Period Ends
April 20, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 20, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 4, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 4, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 15, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 30, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 25, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 25, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 23, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 12, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 15, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 15, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 15, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 8, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 25, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 24, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical, medical and veterinary preparations and articles, other than for immunoassays or in connection with immunoassays, namely, sulfated polysaccharides for pharmaceutical, medical, and veterinary use; pharmaceuticals, medical and veterinary preparations and articles containing polysaccharides for treatment of neurological diseases, disorders or conditions, for treating neuroinflammation, for treatment of fibrotic diseases, disorders or conditions, for treatment of ischemic diseases, disorders or conditions, and for treatment of ophthalmic diseases, disorders or conditions
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical and pharmaceutical advisory, consultancy and information relating to pharmaceutical, medical and veterinary preparations and articles containing polysaccharides for treatment of neurological diseases, disorders or conditions, for treating neuroinflammation, for treatment of fibrotic diseases, disorders or conditions, for treatment of ischemic diseases, disorders or conditions, for treatment of ophthalmic diseases, disorders or conditions
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
044